Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

FSD Pharma Inc Class B (HUGE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.630 -0.010    -1.56%
24/04 - Closed. Currency in CAD ( Disclaimer )
Type:  Equity
Market:  Canada
  • Volume: 67,620
  • Bid/Ask: 0.630 / 0.640
  • Day's Range: 0.630 - 0.660
FSD Pharma B 0.630 -0.010 -1.56%

FSD Pharma Inc Class B Company Profile

 
Get an in-depth profile of FSD Pharma Inc Class B, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

17

Equity Type

ORD

FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.

Contact Information

Address 199 Bay Street Suite 4000
Toronto, M5L 1A9
Canada
Phone 416 854 8884
Fax -

Top Executives

Name Age Since Title
Zeeshan Saeed 54 2021 Founder, CEO, President & Executive Co-Chairman
Anthony John Durkacz 48 2018 Founder & Executive Co-Chairman
Lakshmi P. Kotra 53 2021 CEO of Lucid & Director
Ravinder Kumar - 2022 Member of Advisory Board
Albert H.C. Wong - 2021 Member of Research & Clinical Advisory Board
John McGraw - 2022 Member of Advisory Board
Peter K. Stys - 2021 Member of Research & Clinical Advisory Board
Joga Gobburu - 2021 Member of Regulatory Advisory Board
Mary Melnyk - 2021 Member of Regulatory Advisory Board
Kwok Chow - 2022 Member of the Regulatory Advisory Board
Eleanor N. Fish - 2021 Member of Research & Clinical Advisory Board
Daniele Piomelli - 2022 Member of Research & Clinical Advisory Board
Adnan Bashir 54 2021 Independent Director
David G. P. Allan 82 2022 Member of Advisory Board
Shannon Dunn - 2021 Member of Research & Clinical Advisory Board
Hance Clarke - 2021 Member of Research & Clinical Advisory Board
Jason D. Sawyer - 2022 Member of Advisory Board
Navdeep Jaikaria 61 - Member of Advisory Board
Kevin Harrington 67 2023 Member of Advisory Board
Michael Zapolin 57 2023 Independent Director
Gerald V. David 72 2023 Member of Advisory Board
Eric William Hoskins 62 2023 Independent Director
Alexander Bar - 2023 Member of Advisory Board
Sanjiv Chopra 74 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HUGE Comments

Write your thoughts about FSD Pharma Inc Class B
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Dariusz Brzeski
Dariusz Brzeski Nov 17, 2021 11:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.tipranks.com/news/article/betting-on-marijuana-legalization-bill-analysts-suggest-3-stocks-to-buy
Stephen Appiah
Stephen Appiah Mar 17, 2021 11:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm surprised too. I will not be shocked if it picks up tomorrow.
Sharon Martin
Sharon Martin Mar 17, 2021 8:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What a great surprise this morning.  Anyone know the news on this?
Sharon Martin
Sharon Martin Feb 22, 2021 3:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bought more at the dip?  I hope it is just a dip.
Zahi Aqleh
Zahi Aqleh Feb 22, 2021 3:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what do you think ?
Hassan Shoubah
Hassan Shoubah Feb 22, 2021 3:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
im sorry that i didnt warren u but this stock is worthless. it goes up once every few month only to crash lower then where it ever been. if u see it make all time low and then u still have to wait two months untill it really bottoms maybe then u can find some luck on the way up. just dont waste ur time with it.
Zahi Aqleh
Zahi Aqleh Feb 22, 2021 2:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://eu.app.com/story/news/local/new-jersey/marijuana/2021/02/22/nj-marjuana-legalization-legal ****phil-murphy-sweeney/4535041001/
Zahi Aqleh
Zahi Aqleh Feb 17, 2021 1:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any comments ?
Sharon Martin
Sharon Martin Feb 11, 2021 3:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bought at $3.05.  How high can it go??
קךן םדי
קךן םדי Feb 11, 2021 3:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
too the moon!!
Rashu Dun
Rashu Dun Feb 10, 2021 8:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The market cap is much lower than sndl. Huge potential of upside.
David Larsen
David Larsen Feb 10, 2021 5:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
✨🙌Solid Gains🙌✨
Jose Manuel Lorenzo
Jose Manuel Lorenzo Feb 10, 2021 1:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Loking goog 🔥🔥🔥🔥
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email